British Journal of Cancer
This journal is devoted to publishing cutting edge discovery, translational and clinical cancer research across the broad spectrum of oncology.
Tepotinib in Asian patients with METex14 skipping NSCLC
VISION, the largest study of a MET inhibitor for rare NSCLC with METex14 skipping mutations, shows tepotinib's efficacy and safety in Asian patients align with overall results. It provides the first health-related quality of life assessment for this group, supporting once-daily tepotinib treatment.
Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts
Analyzing data of over 250,000 European men, the TyG index, an indicator of insulin resistance, mediated part of the effect of BMI on prostate cancer death, thus supporting the hypothesis that insulin resistance might be an important pathway for obesity to accelerate prostate cancer progression.